ID   ZJU-0430
DR   CCRID; 4201PAT-CCTCC01127
DR   Wikidata; Q98136527
RX   Patent=CN108048401A;
RX   PubMed=31367188;
CC   Group: Patented cell line.
CC   Problematic cell line: Possibly contaminated. STR profile is 100% identical to that of GBC-SD (Cellosaurus=CVCL_6903).
CC   Registration: International Depositary Authority, China Center for Type Culture Collection; CCTCC C2017174.
CC   Population: Chinese.
CC   Doubling time: 19.81 hours (PubMed=31367188).
CC   Derived from site: In situ; Breast; UBERON=UBERON_0000310.
ST   Source(s): PubMed=31367188
ST   Amelogenin: X,Y
ST   CSF1PO: 11
ST   D13S317: 8,12
ST   D16S539: 11,13
ST   D18S51: 14,21
ST   D19S433: 14,15.2
ST   D21S11: 30,31
ST   D2S1338: 17,24
ST   D3S1358: 17
ST   D5S818: 11
ST   D7S820: 11,12
ST   D8S1179: 10,12
ST   FGA: 23
ST   Penta D: 11,12
ST   Penta E: 12
ST   TH01: 7,10
ST   TPOX: 11
ST   vWA: 16,17
DI   NCIt; C3844; Gallbladder carcinoma
DI   ORDO; Orphanet_56044; Carcinoma of gallbladder and extrahepatic biliary tract
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   74Y
CA   Cancer cell line
DT   Created: 06-09-19; Last updated: 29-06-23; Version: 8
RX   Patent=CN108048401A;
RA   Sun J.-H., Yang X.-M., Zhou F., Zhang Y.-H.;
RT   "Human biliary tract cancer cell lines and application.";
RL   Patent number CN108048401A, 18-May-2018.
RX   PubMed=31367188; DOI=10.1186/s12935-019-0911-1;
RA   Zhou F., Zhang Y.-H., Sun J.-H., Yang X.-M.;
RT   "Characteristics of a novel cell line ZJU-0430 established from human
RT   gallbladder carcinoma.";
RL   Cancer Cell Int. 19:190.1-190.14(2019).